For decades, scientists have been on the hunt for an antiaging drug. Now, some say we may have already found it.
A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat. That includes age-related conditions like Alzheimer’s, osteoarthritis, certain cancers and even mortality.
